Risk of invasive meningococcal disease up with HIV/AIDS

October 29, 2013
Risk of invasive meningococcal disease up with HIV/AIDS
In New York City, people living with HIV/AIDS are at increased risk of contracting invasive meningococcal disease, according to a study published online Oct. 29 in the Annals of Internal Medicine.

(HealthDay)—In New York City, people living with HIV/AIDS (PLWHA) are at increased risk of contracting invasive meningococcal disease (IMD), according to a study published online Oct. 29 in the Annals of Internal Medicine.

Laura Miller, M.P.H., from the New York City Department of Health and Mental Hygiene, and colleagues estimated the risk of IMD and death in PLWHA using IMD surveillance data from 2000 to 2011. Data from 263 reported cases (aged 15 to 64) were matched to death and HIV registries to calculate IMD risk and case fatalities. Age-matched, case-control analyses were conducted using a subset of PLWHA who had a CD4+ count and viral load measurement near the time of their IMD infection.

The researchers identified 55 deaths among the 263 cases of IMD. The average annual incidence rate of IMD was 0.39 per 100,000, and the relative risk of IMD in PLWHA was 10.0 in the study period. Compared with age-matched controls, PLWHA with IMD were 5.3 times as likely to have CD4+ counts less than 200 x 109 cells/L.

"Cost effectiveness and vaccine efficacy studies are needed in order to evaluate the value of a national recommendation for routine meningococcal vaccination of PLWHA," the authors write.

More information: Full Text (subscription or payment may be required)

Related Stories

Meningococcal disease ID'd in men who have sex with men

June 18, 2013

(HealthDay)—Following reports of invasive meningococcal disease (IMD) among men who have sex with men (MSM), the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) has recommended that MSM who have engaged ...

Recommended for you

HVTN 505 vaccine induced antibodies nonspecific for HIV

July 30, 2015

A study by researchers at the National Institute of Allergy and Infectious Diseases and Duke University helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection ...

Vitamin D status related to immune response to HIV-1

June 15, 2015

Vitamin D plays an important part in the human immune response and deficiency can leave individuals less able to fight infections like HIV-1. Now an international team of researchers has found that high-dose vitamin D supplementation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.